Today: 7 February 2026
Subscribe

Caterpillar Stock (NYSE: CAT) Today, Dec. 15, 2025: Price Action, Dividend Update, Analyst Targets, and the 2026 Outlook

Caterpillar Stock (NYSE: CAT) Today, Dec. 15, 2025: Price Action, Dividend Update, Analyst Targets, and the 2026 Outlook

Caterpillar, Inc. (NYSE: CAT) stock is trading in a choppy range on Monday, December 15, 2025, as investors digest last week’s sharp pullback, fresh analyst forecast updates, and a steady drumbeat of longer-term themes—especially power demand tied to AI data centers and ongoing tariff headwinds. As of the latest available quote, CAT is down modestly on the session and has traded roughly between the high-$580s and low-$600s, reflecting a market that is still debating whether the recent surge in expectations has run ahead of near-term fundamentals. Investing.com Caterpillar stock price today: CAT steadies after Friday’s outsized drop CAT entered the
15 December 2025
·····
Bank of America (BAC) Stock Today: Latest News, Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Bank of America (BAC) Stock Today: Latest News, Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Bank of America Corporation (NYSE: BAC) stock is in focus on Monday, December 15, 2025, as investors weigh two big cross-currents: a shifting U.S. rate outlook after the Federal Reserve’s December cut, and fresh momentum behind the “banks-as-AI-efficiency-winners” narrative that has been gaining traction across global financials. As of 15:40 UTC on Dec. 15, BAC shares were trading around $55.54, up about 0.73% on the session. Below is what’s moving the story today—plus the latest forecasts, price targets, and technical read-throughs investors are using to frame the next leg for Bank of America stock. Where BAC stock stands on Dec.
15 December 2025
····
CoreWeave (CRWV) Stock News Today (Dec. 15, 2025): Why Shares Are Falling, Debt Overhang, Insider Selling, and Wall Street Forecasts

CoreWeave (CRWV) Stock News Today (Dec. 15, 2025): Why Shares Are Falling, Debt Overhang, Insider Selling, and Wall Street Forecasts

CoreWeave, Inc. (Nasdaq: CRWV) entered the new week under renewed pressure, extending a volatile stretch that has become familiar for one of the market’s most closely watched AI-infrastructure plays. As of 15:18 UTC (about 10:18 a.m. ET) on Monday, CRWV traded around $72.50, down about 7.75% on the session, after opening near $79.49 and sliding to the low $72 area. The day’s move is less about a single headline and more about a collision of narratives that have dominated CoreWeave’s stock since it went public: explosive AI demand and a huge contracted backlog on one side, and capital intensity, funding
15 December 2025
·····
GE Aerospace Stock (NYSE: GE) in Focus Today: What’s Driving Shares on Dec. 15, 2025—and What Wall Street Expects Next

GE Aerospace Stock (NYSE: GE) in Focus Today: What’s Driving Shares on Dec. 15, 2025—and What Wall Street Expects Next

December 15, 2025 — GE Aerospace stock (NYSE: GE) is back in the spotlight as investors rotate toward industrial leaders with visible demand and durable aftermarket revenue. Shares are trading around the $302 area in Monday’s session, after Friday’s sharp rebound that pushed the stock back near recent highs. MarketBeat+1 The latest move follows a 3.9% jump in the prior session to $299.81, a rally that Zacks attributed to renewed optimism around GE Aerospace’s commercial engine momentum—particularly strong demand for LEAP, GEnx, and GE9X engines and services. Nasdaq Below is a full, up-to-date roundup of the news, forecasts, and analysis
15 December 2025
·····
Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics, Inc. (Nasdaq: FOLD) is back on investors’ radar as the rare-disease biotech extends a strong 2025 run—helped by a milestone quarter of GAAP profitability, expanding global launches for its Pompe franchise, and fresh news tied to a Phase 3 kidney-disease program it licensed earlier this year. On Monday, December 15, 2025, Amicus shares traded around $10.93 intraday after opening near $10.55, with the session range pushing into the low $11 area. Below is a detailed look at the latest Amicus Therapeutics stock news, what Wall Street is forecasting, and the key catalysts (and risks) investors are weighing as
15 December 2025
···
Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Co. shares traded around $461 on Monday, extending a powerful run that has pushed the online used-car retailer back into the market spotlight just days before its scheduled S&P 500 entry. The fresh catalyst on Dec. 15, 2025: Argus Research initiated coverage with a “Buy” rating and a $500 price target, calling out Carvana’s competitive advantages versus traditional dealerships (selection, pricing, quality, and user experience). TradingView But as Carvana stock approaches (and in some sessions has flirted with) a $100+ billion valuation, the debate is getting sharper: is this the start of a new institutional chapter powered by index
15 December 2025
····
Applied Digital (APLD) and the AI Data Center Power Crunch: $16B Backlog, New Buildouts, and the Utilities Rush (Dec. 15, 2025)

Applied Digital (APLD) and the AI Data Center Power Crunch: $16B Backlog, New Buildouts, and the Utilities Rush (Dec. 15, 2025)

The global race to scale artificial intelligence is no longer just about who can secure the most advanced GPUs. Increasingly, it’s about who can secure the hardest inputs of all: grid-ready power, purpose-built data centers, and financing that can survive multi-year construction timelines. That shift is pushing Applied Digital Corporation (NASDAQ: APLD) into the spotlight. The company has positioned itself as a builder and operator of high-density, liquid-cooled “AI factories” — specialized data centers designed to handle modern AI training and inference workloads — and it’s doing it with long-term leases that are starting to look like a prized form
15 December 2025
·····
CNO Financial Group (CNO) Stock Hits a Record High as Jefferies Upgrades to “Buy” — Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

CNO Financial Group (CNO) Stock Hits a Record High as Jefferies Upgrades to “Buy” — Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

CNO Financial Group, Inc. (NYSE: CNO) is in the spotlight on Monday, December 15, 2025, after the stock surged to fresh record territory and logged one of its strongest sessions of the year. Shares traded around $43.26, up roughly 4.9% on the day, after touching an intraday high near $43.40. The move comes as Wall Street digests a notable Jefferies upgrade and revisits CNO’s multi-year profitability targets, capital return story (dividends and buybacks), and the company’s operational pivot in its Worksite business. Investing.com+1 Below is a full roundup of the current developments as of 15.12.2025, along with the latest forecasts
15 December 2025
····
JPMorgan Chase Stock (JPM) Hits Record High on Dec. 15, 2025: Tokenized Money‑Market Fund Launch, Analyst Targets, and What to Watch Next

JPMorgan Chase Stock (JPM) Hits Record High on Dec. 15, 2025: Tokenized Money‑Market Fund Launch, Analyst Targets, and What to Watch Next

JPMorgan Chase & Co. (NYSE: JPM) is starting the week with fresh momentum. On Monday, December 15, 2025, JPMorgan stock touched new record territory as investors weighed a cluster of same-day catalysts—from a new blockchain-based money-market product to updated consumer-credit metrics—against an outlook that still includes one of Wall Street’s biggest open questions for the bank: how higher 2026 expenses will translate into earnings power. As of 15:04 UTC (10:04 a.m. ET) on Dec. 15, JPM shares traded around $320.63, up about 0.7% on the day, after reaching an intraday high of $322.79. Below is what’s driving JPM stock today,
15 December 2025
····
Rocket Lab (RKLB) Stock Climbs After JAXA ‘RAISE And Shine’ Electron Launch as Neutron ‘Hungry Hippo’ Reusable Fairing Clears Final Tests

Rocket Lab (RKLB) Stock Climbs After JAXA ‘RAISE And Shine’ Electron Launch as Neutron ‘Hungry Hippo’ Reusable Fairing Clears Final Tests

December 15, 2025 — Rocket Lab is starting the week with fresh momentum after successfully completing a milestone mission for Japan’s national space agency — and as its next-generation Neutron rocket moves closer to its long-awaited debut. Shares of Rocket Lab (Nasdaq: RKLB) were up about 2.5% in premarket trading on Monday after the company confirmed it deployed a Japanese technology-demonstration spacecraft on its first dedicated mission for the Japan Aerospace Exploration Agency (JAXA). TradingView+1 The stock move follows a volatile but headline-packed stretch for Rocket Lab: a string of late-year Electron launches, an expanding pipeline of government and international
15 December 2025
····
Intel Stock (INTC) Today: SambaNova Deal Buzz, CEO Governance Questions, and Wall Street Forecasts (Dec. 15, 2025)

Intel Stock (INTC) Today: SambaNova Deal Buzz, CEO Governance Questions, and Wall Street Forecasts (Dec. 15, 2025)

Intel Corporation (NASDAQ: INTC) is starting the week in familiar fashion: investors are balancing a high-stakes turnaround story (cost cuts, a reworked foundry strategy, and big-name capital injections) against headline risk (governance scrutiny, geopolitics, and regulatory noise). As of 15:03 UTC on Dec. 15, 2025, Intel shares were trading at $37.56, down 0.66% on the session. But the day’s tape has been choppy. Early trading leaned positive as reports circulated that Intel is nearing a deal for AI chip startup SambaNova Systems—a potential move that could accelerate Intel’s push to regain relevance in AI hardware. Investing.com+1 Below is a comprehensive
15 December 2025
·····
Eli Lilly Stock (LLY) News Today: Retatrutide Breakthrough, Orforglipron FDA Timeline, and Analyst Forecasts on December 15, 2025

Eli Lilly Stock (LLY) News Today: Retatrutide Breakthrough, Orforglipron FDA Timeline, and Analyst Forecasts on December 15, 2025

December 15, 2025 — Eli Lilly and Company (NYSE: LLY) stock is starting the new week in focus as investors weigh a rapid-fire set of catalysts: a headline-grabbing Phase 3 result for next‑generation obesity drug retatrutide, fresh scrutiny around the FDA review timeline for oral GLP‑1 candidate orforglipron, ongoing capacity expansion in the U.S., and a notable analyst price-target tweak hitting the tape today. MarketBeat+3Reuters+3Reuters+3 Below is what’s moving Eli Lilly stock as of 15.12.2025, what the latest forecasts imply, and which risks matter most heading into 2026. Eli Lilly stock price today: where LLY is trading on Dec. 15,
15 December 2025
·····
1 … 1,528 1,529 1,530 1,531 1,532 … 2,713

Stock Market Today

Liberty Global stock price climbs as LBTYA pops and rare Class B spike rattles weekend watchlists

7 February 2026
New York, Feb 7, 2026, 04:55 EST — Market closed Liberty Global’s Class A shares ended Friday at $11.75, up about 4.3%, after a sharp swing in the group’s less-traded Class B stock drew late-week attention on Nasdaq. Class C shares rose about 3.5%, while Class B jumped as much as 139% early in the session and touched a 52-week high of $29.01. (Seeking Alpha) The weekend setup matters because investors head into the new week looking for follow-through ahead of Liberty Global’s next results and after a new push into artificial intelligence tools. On Feb. 3, Liberty Global and
Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop